Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine. Commentary

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases 2004, Vol.39 (5), p.641-651
Hauptverfasser: TALBOT, Thomas R, POEHLING, Katherine A, HARTERT, Tina V, ARBOGAST, Patrick G, HALASA, Natasha B, MITCHEL, Ed, SCHAFFNER, William, CRAIG, Allen S, EDWARDS, Kathryn M, GRIFFIN, Marie R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 651
container_issue 5
container_start_page 641
container_title Clinical infectious diseases
container_volume 39
creator TALBOT, Thomas R
POEHLING, Katherine A
HARTERT, Tina V
ARBOGAST, Patrick G
HALASA, Natasha B
MITCHEL, Ed
SCHAFFNER, William
CRAIG, Allen S
EDWARDS, Kathryn M
GRIFFIN, Marie R
description
format Article
fullrecord <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_16183380</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16183380</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_161833803</originalsourceid><addsrcrecordid>eNqNjc1OwzAQhC1EJcrPO-yFY5Atk9acKxBn1Hu1uJtmq2QdeZ1IvA8PipHgwonTrGa_mbkwa9f6bbNpn9xlvW0bmsfgw5W5Vj1b61yw7dp8vtFxjoWTAAv0fOohYyGF1AFK4XdOhWMjSXTWSFN1BqrogsoLwSQ0jymmGHGAIyuhfn9hTyKkSgTYFcrVKjn9DtXq0v_JxiTn-VSXYcEYWegBdmkcSQrmj1uz6nBQuvvRG3P_8rzfvTYTag13GSWyHqbMY6UPbuOC98H6_3JfyrxjSw</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine. Commentary</title><source>JSTOR Archive Collection A-Z Listing</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>TALBOT, Thomas R ; POEHLING, Katherine A ; HARTERT, Tina V ; ARBOGAST, Patrick G ; HALASA, Natasha B ; MITCHEL, Ed ; SCHAFFNER, William ; CRAIG, Allen S ; EDWARDS, Kathryn M ; GRIFFIN, Marie R</creator><creatorcontrib>TALBOT, Thomas R ; POEHLING, Katherine A ; HARTERT, Tina V ; ARBOGAST, Patrick G ; HALASA, Natasha B ; MITCHEL, Ed ; SCHAFFNER, William ; CRAIG, Allen S ; EDWARDS, Kathryn M ; GRIFFIN, Marie R</creatorcontrib><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>CODEN: CIDIEL</identifier><language>eng</language><publisher>Chicago, IL: University of Chicago Press</publisher><subject>Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Bacterial diseases ; Biological and medical sciences ; Human bacterial diseases ; Infectious diseases ; Medical sciences ; Pharmacology. Drug treatments ; Staphylococcal infections, streptococcal infections, pneumococcal infections</subject><ispartof>Clinical infectious diseases, 2004, Vol.39 (5), p.641-651</ispartof><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4022</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16183380$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>TALBOT, Thomas R</creatorcontrib><creatorcontrib>POEHLING, Katherine A</creatorcontrib><creatorcontrib>HARTERT, Tina V</creatorcontrib><creatorcontrib>ARBOGAST, Patrick G</creatorcontrib><creatorcontrib>HALASA, Natasha B</creatorcontrib><creatorcontrib>MITCHEL, Ed</creatorcontrib><creatorcontrib>SCHAFFNER, William</creatorcontrib><creatorcontrib>CRAIG, Allen S</creatorcontrib><creatorcontrib>EDWARDS, Kathryn M</creatorcontrib><creatorcontrib>GRIFFIN, Marie R</creatorcontrib><title>Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine. Commentary</title><title>Clinical infectious diseases</title><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Bacterial diseases</subject><subject>Biological and medical sciences</subject><subject>Human bacterial diseases</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Staphylococcal infections, streptococcal infections, pneumococcal infections</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNqNjc1OwzAQhC1EJcrPO-yFY5Atk9acKxBn1Hu1uJtmq2QdeZ1IvA8PipHgwonTrGa_mbkwa9f6bbNpn9xlvW0bmsfgw5W5Vj1b61yw7dp8vtFxjoWTAAv0fOohYyGF1AFK4XdOhWMjSXTWSFN1BqrogsoLwSQ0jymmGHGAIyuhfn9hTyKkSgTYFcrVKjn9DtXq0v_JxiTn-VSXYcEYWegBdmkcSQrmj1uz6nBQuvvRG3P_8rzfvTYTag13GSWyHqbMY6UPbuOC98H6_3JfyrxjSw</recordid><startdate>2004</startdate><enddate>2004</enddate><creator>TALBOT, Thomas R</creator><creator>POEHLING, Katherine A</creator><creator>HARTERT, Tina V</creator><creator>ARBOGAST, Patrick G</creator><creator>HALASA, Natasha B</creator><creator>MITCHEL, Ed</creator><creator>SCHAFFNER, William</creator><creator>CRAIG, Allen S</creator><creator>EDWARDS, Kathryn M</creator><creator>GRIFFIN, Marie R</creator><general>University of Chicago Press</general><scope>IQODW</scope></search><sort><creationdate>2004</creationdate><title>Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine. Commentary</title><author>TALBOT, Thomas R ; POEHLING, Katherine A ; HARTERT, Tina V ; ARBOGAST, Patrick G ; HALASA, Natasha B ; MITCHEL, Ed ; SCHAFFNER, William ; CRAIG, Allen S ; EDWARDS, Kathryn M ; GRIFFIN, Marie R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_161833803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Bacterial diseases</topic><topic>Biological and medical sciences</topic><topic>Human bacterial diseases</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Staphylococcal infections, streptococcal infections, pneumococcal infections</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TALBOT, Thomas R</creatorcontrib><creatorcontrib>POEHLING, Katherine A</creatorcontrib><creatorcontrib>HARTERT, Tina V</creatorcontrib><creatorcontrib>ARBOGAST, Patrick G</creatorcontrib><creatorcontrib>HALASA, Natasha B</creatorcontrib><creatorcontrib>MITCHEL, Ed</creatorcontrib><creatorcontrib>SCHAFFNER, William</creatorcontrib><creatorcontrib>CRAIG, Allen S</creatorcontrib><creatorcontrib>EDWARDS, Kathryn M</creatorcontrib><creatorcontrib>GRIFFIN, Marie R</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TALBOT, Thomas R</au><au>POEHLING, Katherine A</au><au>HARTERT, Tina V</au><au>ARBOGAST, Patrick G</au><au>HALASA, Natasha B</au><au>MITCHEL, Ed</au><au>SCHAFFNER, William</au><au>CRAIG, Allen S</au><au>EDWARDS, Kathryn M</au><au>GRIFFIN, Marie R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine. Commentary</atitle><jtitle>Clinical infectious diseases</jtitle><date>2004</date><risdate>2004</risdate><volume>39</volume><issue>5</issue><spage>641</spage><epage>651</epage><pages>641-651</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><coden>CIDIEL</coden><cop>Chicago, IL</cop><pub>University of Chicago Press</pub></addata></record>
fulltext fulltext
identifier ISSN: 1058-4838
ispartof Clinical infectious diseases, 2004, Vol.39 (5), p.641-651
issn 1058-4838
1537-6591
language eng
recordid cdi_pascalfrancis_primary_16183380
source JSTOR Archive Collection A-Z Listing; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals
subjects Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
Bacterial diseases
Biological and medical sciences
Human bacterial diseases
Infectious diseases
Medical sciences
Pharmacology. Drug treatments
Staphylococcal infections, streptococcal infections, pneumococcal infections
title Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine. Commentary
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T07%3A08%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduction%20in%20high%20rates%20of%20antibiotic-nonsusceptible%20invasive%20pneumococcal%20disease%20in%20Tennessee%20after%20introduction%20of%20the%20pneumococcal%20conjugate%20vaccine.%20Commentary&rft.jtitle=Clinical%20infectious%20diseases&rft.au=TALBOT,%20Thomas%20R&rft.date=2004&rft.volume=39&rft.issue=5&rft.spage=641&rft.epage=651&rft.pages=641-651&rft.issn=1058-4838&rft.eissn=1537-6591&rft.coden=CIDIEL&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E16183380%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true